Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Deloitte
McKinsey
Johnson and Johnson
Merck
Cipla
McKesson
Mallinckrodt
Moodys

Generated: October 24, 2017

DrugPatentWatch Database Preview

INDERIDE LA 160/50 Drug Profile

« Back to Dashboard

Which patents cover Inderide La 160/50, and what generic Inderide La 160/50 alternatives are available?

Inderide La 160/50 is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in INDERIDE LA 160/50 is hydrochlorothiazide; propranolol hydrochloride. There are thirty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

Summary for Tradename: INDERIDE LA 160/50

US Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list713
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INDERIDE LA 160/50 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
INDERIDE LA 160/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-003Jul 3, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: INDERIDE LA 160/50

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
INDERIDE LA 160/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-003Jul 3, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Medtronic
Chinese Patent Office
Julphar
QuintilesIMS
McKesson
Merck
Daiichi Sankyo
Chubb
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot